SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-007412
Filing Date
2018-03-14
Accepted
2018-03-14 17:41:10
Documents
2
Period of Report
2018-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3668
2 EX-24 DOCUMENT attachment1.htm EX-24 2759
  Complete submission text file 0000899243-18-007412.txt   7779
Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
FALBERG KATHRYN E (Reporting) CIK: 0001206977 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38419 | Film No.: 18690435

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 650-489-9000
Arcus Biosciences, Inc. (Issuer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations